November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Questions DHS Misuse of Customs Summons Authority to Chill First Amendment Protected Speech Online
- Wyden Outlines Priorities for New Child Welfare Lead to Protect Vulnerable Children
- Wyden, Warner Call on Trump to Help Seniors When Insurance Companies Drop Doctors from Their Plans
- Continuing Epstein Investigation, Wyden Releases New Analysis Detailing How Top JPMorgan Chase Executives Enabled Epstein’s Sex Trafficking Operation
- Wyden Statement on Public Charge Rule